Isabel Grote

5PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 06, 2023
Frequency of genetic alterations differs in advanced breast cancer between metastatic sites.

Isabel Grote, Alexandra Poppe, Ulrich Lehmann

|Jul 16, 2022
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.

Isabel Grote, Stephan Bartels, Henriette Christgen

|Nov 15, 2021
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.

Isabel Grote, Stephan Bartels, Leonie Kandt

Pageof 1